The European Commission has approved Roche’s PiaSky (crovalimab) to treat adults and adolescents with paroxysmal nocturnal hemoglobinuria (PNH), ages 12 and older who weigh at least 40 kilograms (88 pounds). PiaSky is the first treatment for PNH in the European Union that’s administered subcutaneously (under the skin) once a…
Read more
Have you heard the term “invisible illness”? The Invisible Disabilities Association defines it as “a physical, mental, or neurological condition that is not visible from the outside, yet can limit or challenge a person’s movements, senses, or activities.” That includes chronic conditions such as aplastic anemia and…
When I was diagnosed with aplastic anemia and paroxysmal nocturnal hemoglobinuria (PNH), I was so focused on managing my blood disorders that I neglected to work out. One day, I went to see my PNH specialist. As I updated him on my health since my last…
Get regular updates delivered to your inbox.
